← Leaderboards
Dennis G. Moledina
Yale University
$4,592,286
Attributed
$5,330,196
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,330,196 · 3
By mechanism
R01$4,410,686 · 2
K23$919,510 · 1
Top collaborators
- Meghan E. Sise2 shared
Most similar at Yale University
Same institution · by research overlap
- Lloyd G Cantley$26,240,423
- Julie A Womack$2,505,229
- Laura R. Ment$24,806,596
- Mark J Shlomchik$51,286,869
- Evelyn Hsieh$3,189,238
Others in their field
Other Emerging Leaders on “Cohort”
- Leonard Freedman · Leidos Biomedical Research, Inc.$70,225,348
- April Brinkoetter · Hungry Heart Media, Inc.$57,302,265
- Julie Ake · National Institute Of Allergy And Infectious Diseases$52,642,120
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Scott Hensley · University Of Pennsylvania$47,346,110
- Susan M Landau · University Of California Berkeley$47,252,026
Research focus
CohortClinical TrialsKidneyPharmaceutical PreparationsEnrollmentUrineInflammationInterstitial NephritisPatient CareFuturePlasmaRenal FunctionTherapeutic ImmunosuppressionDiagnostic BiomarkerAcuteHistologicDiagnosisBiobankBiological MarkersParticipantRenal DamageKidney BiopsyDiagnostic TestsImage
Grant awards (12)
Rapid Diagnosis and Treatment Response Phenotyping of Immune Checkpoint Inhibitor-Associated Acute Interstitial Nephritis$719,851
R01 · FY2025 · DK · contact PI
Biomarkers for acute interstitial nephritis in humans$532,801
R01 · FY2025 · DK · contact PI
Rapid Diagnosis and Treatment Response Phenotyping of Immune Checkpoint Inhibitor-Associated Acute Interstitial Nephritis$755,970
R01 · FY2024 · DK · contact PI
Biomarkers for acute interstitial nephritis in humans$552,936
R01 · FY2024 · DK · contact PI
Biomarkers for acute interstitial nephritis in humans$606,218
R01 · FY2023 · DK · contact PI
Biomarkers for acute interstitial nephritis in humans$610,901
R01 · FY2022 · DK · contact PI
Identification of Non-Invasive Biomarkers and Indices for Diagnosis of Drug-Induced Acute Interstitial Nephritis$183,097
K23 · FY2022 · DK · contact PI
Biomarkers for acute interstitial nephritis in humans$632,009
R01 · FY2021 · DK · contact PI
Identification of Non-Invasive Biomarkers and Indices for Diagnosis of Drug-Induced Acute Interstitial Nephritis$184,023
K23 · FY2021 · DK · contact PI
Identification of Non-Invasive Biomarkers and Indices for Diagnosis of Drug-Induced Acute Interstitial Nephritis$182,940
K23 · FY2020 · DK · contact PI
Identification of Non-Invasive Biomarkers and Indices for Diagnosis of Drug-Induced Acute Interstitial Nephritis$183,637
K23 · FY2019 · DK · contact PI
Identification of Non-Invasive Biomarkers and Indices for Diagnosis of Drug-Induced Acute Interstitial Nephritis$185,813
K23 · FY2018 · DK · contact PI